$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > T药

阿替利珠单抗|上市信息

阿替利珠单抗 (T药)一线治疗转移性非小细胞肺癌患者获欧盟积极审
美国FDA批准阿替利珠单抗联合贝伐珠单抗用于一线肝癌治疗(IMbrave
阿替利珠单抗(T药)在国内获批上市!小细胞肺癌进入免疫治疗新时代!

阿替利珠单抗|最新研究

Lancet丨肺癌, 阿替利珠单抗(T药)术后辅助治疗显著延长“无癌生存”